BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,908,578 | -1.6% | 1,923,000 | 0.0% | 0.05% | +1.9% |
| Q2 2023 | $1,939,634 | -40.7% | 1,923,000 | -38.8% | 0.05% | -40.9% |
| Q1 2023 | $3,270,684 | -3.4% | 3,143,000 | 0.0% | 0.09% | -3.3% |
| Q4 2022 | $3,386,583 | +7.9% | 3,143,000 | 0.0% | 0.09% | +2.2% |
| Q3 2022 | $3,139,000 | -0.1% | 3,143,000 | 0.0% | 0.09% | +4.7% |
| Q2 2022 | $3,141,000 | -0.9% | 3,143,000 | 0.0% | 0.08% | +16.4% |
| Q1 2022 | $3,168,000 | +39.1% | 3,143,000 | +44.0% | 0.07% | +58.7% |
| Q4 2021 | $2,277,000 | +8.0% | 2,183,000 | +3.3% | 0.05% | 0.0% |
| Q3 2021 | $2,108,000 | -13.7% | 2,114,000 | -13.0% | 0.05% | -16.4% |
| Q2 2021 | $2,442,000 | – | 2,429,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 32,443,000 | $33,719,632 | 2.49% |
| MACKAY SHIELDS LLC | 76,393,000 | $80,060,298 | 2.20% |
| Lombard Odier Asset Management (Europe) Ltd | 15,560,000 | $16,178,043 | 0.80% |
| Sonora Investment Management Group, LLC | 7,840,000 | $8,152,676 | 0.71% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,220,000 | $26,430,712 | 0.50% |
| ZAZOVE ASSOCIATES LLC | 3,750,000 | $3,898 | 0.36% |
| LOOMIS SAYLES & CO L P | 2,059,347 | $200,251 | 0.35% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,332,000 | $1,389,779 | 0.34% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,069 | 0.24% |
| RATIONAL ADVISORS LLC | 1,233,000 | $1,286,026 | 0.10% |